/images/ppid_59c68470-image-176907258187586035.webp)
/images/ppid_59c68470-image-176882509156429611.webp)
/images/ppid_59c68470-image-176899753114010993.webp)
/images/ppid_59c68470-image-176881002807631656.webp)
What is the story about?
Shares of TTK Healthcare Ltd. were trading about 3% lower on Thursday, January 22, after the company reported a weak set of earnings for the December quarter (Q3FY26).
The company's net profit declined sharply by 34.4% year-on-year to ₹10.5 crore, compared with ₹16.7 crore in the same quarter last year.
Revenue saw a modest increase of 2.2% to ₹209 crore from ₹205 crore, pointing to subdued topline growth during the quarter.
Operating performance also softened, with EBITDA falling 6% year-on-year to ₹7.2 crore from ₹8 crore. As a result, operating margins contracted to 3.5% from 3.9% in the year-ago quarter.
The company's net profit declined sharply by 34.4% year-on-year to ₹10.5 crore, compared with ₹16.7 crore in the same quarter last year.
Revenue saw a modest increase of 2.2% to ₹209 crore from ₹205 crore, pointing to subdued topline growth during the quarter.
Operating performance also softened, with EBITDA falling 6% year-on-year to ₹7.2 crore from ₹8 crore. As a result, operating margins contracted to 3.5% from 3.9% in the year-ago quarter.
/images/ppid_59c68470-image-176901008621613712.webp)
/images/ppid_59c68470-image-176898759963686752.webp)
/images/ppid_59c68470-image-176890008533324593.webp)
/images/ppid_59c68470-image-176890012059985197.webp)
/images/ppid_59c68470-image-176898506016097133.webp)
/images/ppid_59c68470-image-176905756573492245.webp)
/images/ppid_59c68470-image-176899504228667042.webp)
/images/ppid_59c68470-image-176891760712812654.webp)